SRINIVAS AKKARAJU Insider Trading $ICPT INTERCEPT PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for SRINIVAS AKKARAJU.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of SRINIVAS AKKARAJU. SRINIVAS AKKARAJU is Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in aTYR PHARMA INC ($LIFE) and Director in ADURO BIOTECH, INC. ($ADRO) and Director in ZS Pharma, Inc. ($ZSPH) and Director in Principia Biopharma Inc. ($PRNB) and Director in Versartis, Inc. ($VSAR) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Jiya Acquisition Corp. ($JYAC).

SRINIVAS AKKARAJU in INTERCEPT PHARMACEUTICALS, INC.

Trading Symbol: ICPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SRINIVAS AKKARAJU: Director
Holdings: 477,129 shares
Current Value: $54,187,541
Latest Transaction: Mar 12 2021
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of SRINIVAS AKKARAJU in INTERCEPT PHARMACEUTICALS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ARAV, LIFE, ADRO, ICPT, JYAC, PRNB, SGEN, SYRS, ZSPH

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 12 2021ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorBuyP21.29147,0003,129,630640,688493.7 K to 640.7 K (+29.78 %)
Mar 12 2021ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorBuyP21.5516,559356,846493,688477.1 K to 493.7 K (+3.47 %)
Mar 12 2021ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorBuyP20.8373,4411,529,776477,129403.7 K to 477.1 K (+18.19 %)
Jun 01 2020ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorOption ExerciseA72.742,966215,7472,966
Jun 01 2020ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorGrantA0.001,595023,12121.5 K to 23.1 K (+7.41 %)
Aug 30 2019ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorBuyP60.325,207314,086403,688398.5 K to 403.7 K (+1.31 %)
Aug 22 2019ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorGrantA64.301,18075,874398,481397.3 K to 398.5 K (+0.30 %)
Aug 22 2019ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorGrantA67.1229,0001,946,480397,301368.3 K to 397.3 K (+7.87 %)
Aug 22 2019ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorGrantA65.8537,6042,476,223368,301330.7 K to 368.3 K (+11.37 %)
Jun 21 2019ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorOption ExerciseA82.252,174178,8122,174
Jun 21 2019ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorGrantA0.001,570021,52620 K to 21.5 K (+7.87 %)
May 14 2019ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorGrantA83.50119,7609,999,960330,697210.9 K to 330.7 K (+56.78 %)
Apr 29 2019ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorOption ExerciseM31.901,00131,932979
Apr 29 2019ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorOption ExerciseM21.502,49953,7290
Apr 29 2019ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorBuyM31.901,00131,93219,95619 K to 20 K (+5.28 %)
Apr 29 2019ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorBuyM21.502,49953,72918,95516.5 K to 19 K (+15.19 %)
Feb 21 2019ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorSellS128.7823,4383,018,346210,937234.4 K to 210.9 K (-10.00 %)
Jun 22 2018ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorOption ExerciseA85.122,748233,9102,748
Jun 22 2018ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorGrantA0.001,787016,45614.7 K to 16.5 K (+12.18 %)
Apr 09 2018ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorGrantA64.00234,37515,000,000234,3750 to 234.4 K
Jun 29 2017ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorOption ExerciseA122.012,036248,4122,036
Jun 29 2017ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorGrantA0.001,423014,66913.2 K to 14.7 K (+10.74 %)
Jul 21 2016ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorOption ExerciseA145.221,598232,0621,598
Jul 21 2016ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorGrantA0.001,204013,24612 K to 13.2 K (+10.00 %)
May 17 2016ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorOption ExerciseM21.501,50032,2502,499
May 17 2016ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorBuyM21.501,50032,25012,04210.5 K to 12 K (+14.23 %)
Nov 27 2015ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorOption ExerciseA183.621,750321,3351,750
Nov 27 2015ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorGrantA0.00650010,5429.9 K to 10.5 K (+6.57 %)
Oct 30 2015ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorOption ExerciseM21.501,25026,8753,999
Oct 30 2015ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorBuyM21.501,25026,8759,8928.6 K to 9.9 K (+14.46 %)
May 22 2015ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorOption ExerciseM21.501,00021,5005,249
May 22 2015ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorBuyM21.501,00021,5008,6427.6 K to 8.6 K (+13.09 %)

Page:   1